1. Peripheral blood leucocytes from human male volunteers and from male rats were incubated in vitro in the presence of 14C-labelled linoleic acid (["GILA) 4. Utilization of ["GILA by the A6-desaturase was only a minor route of its metabolism in both human and rat leucocytes.
The essential fatty acids (EFA) have been recognized as being essential to humans for 35 years (Hansen et al. 1947) but the EFA status of humans is still only assessed on the basis of plasma and erythrocyte fatty acid composition. Static measurement of fatty acid composition can identify proportional imbalances of fatty acids, but it would be valuable if a metabolically active cell population were available in which EFA metabolism could be measured by in vitro techniques. Both platelets and peripheral blood leucocytes might be appropriate for this purpose. The platelet has been widely used to determine prostaglandin (PG) synthesis from arachidonic acid (Bills et al. 1977) and the leucocyte has been similarly used to study leukotriene synthesis from arachidonic acid (Borgeat et al. 1976) . In neither case has the metabolism of other EFA been documented in any detail.
In the present study we have assessed the uptake of '*C-labelled linoleic acid ([14C]LA) and 3H-labelled arachidonic acid ([3H]AA) into mixed human peripheral blood leucocytes. We present evidence that both fatty acids are readily taken up into the leucocyte lipid pools but, in comparison with the rat, the pattern of incorporation is markedly different. In both man and the rat, A6-desaturation was a minor route of [14C]LA metabolism, but did appear to be lower in man than in the rat. Basal PG synthesis, although readily monitored in the medium surrounding the leucocytes following incubation with [3H]AA, was also a minor metabolic pathway of [3H]AA.
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Leucocyte preparation
Isolation of peripheral blood leucocytes from healthy male volunteers (aged 3 W 5 years) and from male Wistar rats (250-300 g) was performed as previously described (Keeling et al. 1981) . Heparinized blood (50 ml) was mixed with 10 ml dextran in saline (9 g sodium chloride/l, Dextraven 150; Fisons) and the erythrocytes and platelets allowed to sediment for 20-30 min. The leucocyte-rich supernatant fraction was decanted into 15 ml test-tubes and centrifuged at 250 g for 5 min. The supernatant plasma fraction was discarded and the leucocytes resuspended in 3 ml deionized water for 15 s to lyse contaminating erythrocytes. Quadruple-strength Hartmann's solution (1.0 ml) was added to restore osmolarity and the leucocytes were then centrifuged for 3 min at 250 g and resuspended in the incubation medium.
Leucocyte incubation
The incubation medium was TC 199 minimal essential medium (Wellcome) with 20 mM-HEPES (Sigma) added as a buffer (final pH 7.4). The leucocytes were resuspended in varying amounts of medium (5-20 ml) according to the experiment. Leucocyte counts and viability tests were performed before and after incubations. Viability was found to be =-95%, as found in previous studies under similar conditions (Keeling et af. 1981) .
For the A6-desaturase studies in intact leucocytes, 0.5 pCi [1-14C]LA (10 nmol; Amersham International) was incubated with the leucocytes for 30 min at 37". In the leucocyte and rat liver microsomal fractions, A6-desaturase assays were run using appropriate cofactors and the particle-free supernatant fractions added to a Tris-buffered medium as previously described (Cunnane & Wahle, 1981) .
The time-course and lipid distribution studies were carried out by resuspending the leucocytesinTC 199medium with0.5 pCieach~f[l-'~C]LAand [5,6,8,9,1 1,12,14,15-3H] AA (Amersham International) simultaneously.
Stimulation of the leucocytes was carried out with either latex beads or unopsonized zymosan (Sigma). Latex beads were incubated with the leucocytes in the ratio 20: 1, and zymosan in the ratio 2: 1, or approximately 100-150 pg zymosan/ml incubation medium. The incubations with zymosan were done on a time-course basis: 1 h incubation before stimulation, followed by sampling at 1 h and 2 h after stimulation. Comparisons of lipid incorporation and distribution were made between stimulated and unstimulated cells.
Lipid extraction
To determine the lipid incorporation and distribution of [14C]LA and [3H]AA, the leucocyte lipids were extracted with chloroform-methanol (2: 1, v/v) containing butylated hydroxytoluene (100 mg/l) as an antioxidant. Lipid extracts were spotted on Whatman LK5D pre-coated plates (Pierce and Warriner) which were developed with the following solvents: for neutral lipids (light petroleum (b.p. 40-60)-diethyl ether-acetic acid-methanol (85: 15: 2.5: 1, by vol.); for phospholipids, chloroform-methanol-water (60:30:4, by vol.). After development, radioactive peaks on all plates were identified using a radiochromatogram scanner (Panax). Lipid bands on the plates were further identified by charring and comparison with authentic standards.
For the A6-desaturase assay, the incubation was stopped and the lipids saponified with ethanolic potassim hydroxide followed by acidification, extraction with diethyl ether, neutralization, and methylation with diazomethane (Cunnane & Wahle, 198 1) . Argentation thin-layer chromatography was used for fatty acid separation, according to the number of double bonds, with the solvent hexane-diethyl ether (40: 60, v/v) . PGE, and PGF,, synthesis from [3H]AA was determined by acidification of the incubation mixture to pH 3.2, extraction of the prostaglandins with diethyl ether-ethyl acetate (4: 1, v/v) and thin-layer chromatographic separation of PGE, and PGF,, using the organic phase of a mixture of ethyl acetate-iso-octane-acetic acid-water (10: 5 : 2: 11, by vol.) as solvent.
For all radioactivity studies, bands of silica containing radioactivity were scraped into scintillation vials, 10 ml toluene-based scintillation fluid was added and the radioactivity determined using a liquid-scintillation counter (Intertechnique).
Statistical analyses were performed using Student's paired t-test.
RESULTS
[14C]LA and [3H]AA uptake Fig. 1 shows the time-course of [14C]LA and [3H]AA uptake from the incubation medium by the leucocytes. For both fatty acids, at least 50% of the label had been incorporated into the leucocytes within 15min, and within 30min incorporation was maximal. The amount of [14C]LA remaining in the incubation medium was significantly less than that of J3H]AA after 40 min. [3H]AA incorporation into lipids in the incubation medium The distribution of [3H]AA in the lipids present in the incubation medium showed a different pattern from that in the leucocyte intracellular lipids (Fig. 4) Mean values were significantly different from those of human leucocytes: *P < 0.05, **P < 0.01. Mean values were significantly different from those of intact human or rat leucocytes: t P < 0.05, $P < 0.01. Table 2 < 1 % of the [14C]LA was incorporated into TG in the rat leucocytes whereas in the human leucocytes it was 60%. Table 3 illustrates the differences of desaturation of [14C]LA by leucocytes from man and the rat. The intact rat leucocytes had an eightfold greater activity of 65-and A6-desaturases combined than did human leucocytes (measured on the basis of pmol [14C]LA converted/ 10' cells). Both rat and human leucocytes were less capable of desaturating [14C]LA than was rat liver (P < 0.001).
Incorporation of
Comparison with rat leucocytes
DISCUSSION
Our observtions suggest that the human peripheral blood leucocyte may be a useful cell in which to study EFA metabolism. Both [14C]LA and [3H]AA were rapidly incorporated into TG and PC lipid pools whereas, in the rat, the majority of these labelled fatty acids remained as the free acids. These results give a possible explanation for the apparent difference in desaturation of [14C]LA between humans and the rat, which we have observed. If this difference (Table 3) is a real one, it may be linked to a difference in the rate of uptake of [14C]LA into the leucocyte lipids and not just to the rate of conversion of LA to its desaturase products (Table 2) . In rat leucocytes, > 60% of the ['*C]LA remained as the FFA for at least 1 h whereas, in human leucocytes, the intracellular pool of [14C]LA only reached 30%, and after 1 h was < 10%. Hence the availability of free LA to the desaturase enzyme may be significantly less in the human leucocytes.
Our results also suggest that the TG pool is an important intermediate pool in the incorporation of EFA into human leucocyte cellular lipids. It was the major pool of [14C]LA and 13H]AA accumulation for as long as 9 h (Fig. 2) . In addition, since the FFA pool of
[14C]LA and [3H]AA was < 10% of the total after 30 min, the TG pool may be the short-term precursor pool of these fatty acids for both desaturases and PG synthesis respectively. These results contrast with those in platelets in which AA accumulates almost exclusively in phospholipids (Bills et al. 1977 ). This metabolic difference with the leucocytes suggests that the functional difference between these cells may be linked to a difference in their EFA metabolism.
Mouse periotoneal macrophages (Bonney er al. 1978 (Bonney er al. , 1981 ; Scott et af. 1980) also esterify AA into phospholipids much more rapidly than do human peripheral blood leucocytes. However, rabbit peritoneal macrophages are similar to human peripheral blood leucocytes in their metabolism of LA (Elsbach, 1963 (Elsbach, ,1964 Cook et af. 1983) . In fact, the 24 h time-course of [14C]LA incorporation into rabbit peritoneal macrophages is virtually identical to that in human peripheral blood leucocytes. Since EFA metabolism in human tissues appears to be more like that in the rabbit and guinea-pig than that in the rat or mouse (Stone et al. 1979 ) EFA studies of relevance to man might therefore be more suitably conducted using the rabbit or guinea-pig.
We have confirmed previous reports that production of PGE, and PGF,, by human peripheral blood leucocytes is low and is substantially lower than production by tissue macrophages (Morley, 1981) . The low production of PG by peripheral blood leucocytes may be related to the high incorporation of AA into the TG rather than the phospholipid pool. This contrasts with tissue macrophages which readily produce PG but also incorporate AA into phospholipids. The rapid and long-term uptake of AA into TG by peripheral blood leucocytes may therefore be a protective mechanism preventing rapid release of AA for conversion to PG or leukotrienes. Our results also confirm that of Elsbach (1972) and suggest that peripheral blood leucocytes do not alter their uptake of EFA in response to phagocytic stimuli such as latex beads or zymosan.
Our time-course studies of [3H]AA metabolism to PGE, and PGF,, (Figs. 3 and 4 ) did not establish which pool was the source of free [3H]AA for the cyclo-oxygenase enzyme under physiological conditions. This was because the amount of [3H]PGE, and [3H]PGF,, secreted by the leucocytes in I h was only 2% of the total intracellular radioactivity, although it accounted for 25-30% of the radioactivity in the incubation medium. A 2% change in the amount of radioactivity associated with any of the lipid fractions was within the standard error of the results.
We conclude that the peripheral blood leucocyte may be valuable in the study of EFA metabolism in intact human cells. The possibility that the zinc status of the leucocytes may influence the lipid distribution profile of EFA in the leucocytes, as previously demonstrated in the rat (Cunnane & Huang, 1982) , remains to be elucidated. The rapid uptake and distribution of EFA into four main leucocyte lipid fractions and the ease of sampling and assay should facilitate identification of defects in EFA metabolism in human diseases.
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